Cargando…

The effect of intravenous tissue-type plasminogen activator in a rat model of embolic cerebral ischemia.

Thrombolytic agents may be useful in the treatment of cerebral ischemia caused by arterial thrombosis or embolic occlusion. A trial of intravenous human tissue-type plasminogen activator (rt-PA) was carried out in seven male Sprague-Dawley rats subjected to embolic cerebral ischemia, with eight cont...

Descripción completa

Detalles Bibliográficos
Autores principales:	Penar, P. L., Greer, C. A.
Formato:	Texto
Lenguaje:	English
Publicado:	Yale Journal of Biology and Medicine 1987
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2590095/ https://www.ncbi.nlm.nih.gov/pubmed/3111108

Ejemplares similares

Effects of erythropoietin combined with tissue plasminogen activator on the rats following cerebral ischemia and reperfusion
por: Wang, Rongliang, et al.
Publicado: (2016)

Pericyte protection by edaravone after tissue plasminogen activator treatment in rat cerebral ischemia
por: Deguchi, Kentaro, et al.
Publicado: (2014)

Unruptured Cerebral Aneurysm Detected after Intravenous Tissue Plasminogen Activator for Stroke
por: Yoneda, Yukihiro, et al.
Publicado: (2009)

Evaluation of Cerebral Perfusion in Patients Undergoing Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis
por: HIRANO, Teruyuki
Publicado: (2015)

A Review of the Mechanisms of Blood-Brain Barrier Permeability by Tissue-Type Plasminogen Activator Treatment for Cerebral Ischemia
por: Suzuki, Yasuhiro, et al.
Publicado: (2016)

Homocystinuria with Cerebral Venous Sinus Thrombosis: Excellent Recovery with Intravenous Recombinant Tissue Plasminogen Activator
por: Gowda, Vykuntaraju K, et al.
Publicado: (2017)

Neuroprotective Consequences of Postconditioning on Embolic Model of Cerebral Ischemia in Rat
por: Rezazadeh, Hosseinali, et al.
Publicado: (2013)

Emergency Superficial Temporal Artery to Middle Cerebral Artery Bypass after Intravenous Recombinant Tissue Plasminogen Activator Administration for Acute Cerebral Ischemia in a Patient with Moyamoya Disease
por: Tabuchi, Sadaharu, et al.
Publicado: (2013)

Imaging Evidence for Cerebral Hyperperfusion Syndrome after Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke
por: Zhang, Yi, et al.
Publicado: (2016)

Tissue plasminogen activator; identifying major barriers related to intravenous injection in ischemic acute cerebral infraction
por: Khorvash, Fariborz, et al.
Publicado: (2017)

Neuroprotective effect of p-coumaric acid in rat model of embolic cerebral ischemia
por: Guven, Mustafa, et al.
Publicado: (2015)

Hemorrhagic Transformation after Intravenous Tissue Plasminogen Activator Administration in Acute Distal Middle Cerebral Artery Occlusion
por: Lee, Chan-Hyuk, et al.
Publicado: (2022)

Generation and characterization of tissue-type plasminogen activator transgenic rats
por: Ito, Yusuke, et al.
Publicado: (2017)

Intravenous tissue plasminogen activator, ischemic stroke, and the risk of Kounis Syndrome
por: Kounis, Nicholas G., et al.
Publicado: (2011)

Correction to: Generation and characterization of tissue-type plasminogen activator transgenic rats
por: Ito, Yusuke, et al.
Publicado: (2017)

Tissue-type plasminogen activator contributes to remodeling of the rat ductus arteriosus
por: Saito, Junichi, et al.
Publicado: (2018)

Tissue Plasminogen Activator and Plasminogen Activator Inhibitor 1 Contribute to Sonic Hedgehog-Induced In Vitro Cerebral Angiogenesis
por: Teng, Hua, et al.
Publicado: (2012)

Tissue Plasminogen Activator Use in Cardiac Arrest Secondary to Fulminant Pulmonary Embolism
por: Yousuf, Tariq, et al.
Publicado: (2016)

Central Venous Catheter-directed Tissue Plasminogen Activator in Massive Pulmonary Embolism
por: Gulati, Vishal, et al.
Publicado: (2018)

Medicolegal Considerations with Intravenous Tissue Plasminogen Activator in Stroke: A Systematic Review
por: Bhatt, Archit, et al.
Publicado: (2013)

Intravenous Tissue Plasminogen Activator for an Ischemic Stroke with Occult Double Primary Cancer
por: Yoneda, Yukihiro, et al.
Publicado: (2014)

Mouse ovarian granulosa cells produce urokinase-type plasminogen activator, whereas the corresponding rat cells produce tissue-type plasminogen activator
Publicado: (1987)

Tissue plasminogen activator disrupts the blood-brain barrier through increasing the inflammatory response mediated by pericytes after cerebral ischemia
por: Yang, Eryan, et al.
Publicado: (2019)

Successful thrombolytic therapy with recombinant tissue-type plasminogen activator for massive pulmonary embolism -A case report-
por: Kim, Min Soo, et al.
Publicado: (2010)

Different Doses of Intravenous Tissue-Type Plasminogen Activator for Acute Ischemic Stroke: A Network Meta-Analysis
por: Li, Bing-Hu, et al.
Publicado: (2022)

Embolic occlusion of internal carotid artery in conscious rats: Immediate effects of cerebral ischemia
por: Toung, Thomas J. K., et al.
Publicado: (2023)

Tissue Plasminogen Activator and MRI Signs of Cerebral Small Vessel Disease
por: Dobrynina, Larisa A., et al.
Publicado: (2019)

Structural basis of specific inhibition of tissue-type plasminogen activator by plasminogen activators inhibitor-1
por: Gong, Lihu, et al.
Publicado: (2016)

Role of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in psychological stress and depression
por: Tsai, Shih-Jen
Publicado: (2017)

Outcomes of Endovascular Mechanical Thrombectomy and Intravenous Tissue Plasminogen Activator for the Treatment of Vertebrobasilar Stroke
por: Brinjikji, Waleed, et al.
Publicado: (2014)

Intra-arterial administration of recombinant tissue-type plasminogen activator (rt-PA) causes more intracranial bleeding than does intravenous rt-PA in a transient rat middle cerebral artery occlusion model
por: Crumrine, R Christian, et al.
Publicado: (2011)

Effects of Angiopoietin-1 on Hemorrhagic Transformation and Cerebral Edema after Tissue Plasminogen Activator Treatment for Ischemic Stroke in Rats
por: Kawamura, Kunio, et al.
Publicado: (2014)

Therapeutic effect of recombinant tissue plasminogen activator on acute cerebral infarction at different times
por: Liu, Ming, et al.
Publicado: (2013)

Effect of Plasminogen Activator Inhibitor-1 and Tissue Plasminogen Activator Polymorphisms on Susceptibility to Type 2 Diabetes in Malaysian Subjects
por: Al-Hamodi, Zaid, et al.
Publicado: (2012)

Clinical efficacy of low dose recombinant tissue-type plasminogen activator for the treatment of acute intermediate-risk pulmonary embolism
por: Zhang, Ling-Yun, et al.
Publicado: (2018)

Immunocytochemical demonstration of tissue-type plasminogen activator in endocrine cells of the rat pituitary gland
Publicado: (1985)

An Endothelial Storage Granule for Tissue-Type Plasminogen Activator
por: Emeis, J.J., et al.
Publicado: (1997)

Roles of the tissue-type plasminogen activator in immune response
por: Seillier, Célia, et al.
Publicado: (2022)

Combined Treatment With 2-(2-Benzofu-Ranyl)-2-Imidazoline and Recombinant Tissue Plasminogen Activator Protects Blood–Brain Barrier Integrity in a Rat Model of Embolic Middle Cerebral Artery Occlusion
por: Zhang, Linlei, et al.
Publicado: (2020)

Pharmacokinetics and thrombolytic effects of the recombinant tissue-type plasminogen activator in horses
por: Bäumer, Wolfgang, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1up39r6pdve7hs5ie4fcg1fjqn